… with good risk cytogenetics and a low predicted risk of relapse … Chimerism status will be
a critical determinant of immune … as the most important predictor of relapse. On the basis of …

… chimerism trajectory occur in the setting of disease relapse/… quantifying donor chimerism
levels to confirm graft failure (… factors, such as patient functional status and disease-specific …

… from complete donor chimerism to mixed donor chimerism of sex … status after the second
month post-HSCT was a predictor of CIR. … , disease status, and donor intention can be helpful in …

… These factors are strictly interconnected and valuable … the previous ones, spreading to
relapse prediction. Indeed, we … regimen, disease type and status, negative history of steroid …

… cfDNA chimerism status in patients with complications after … is not possible to establish the
predictive value of recipient cfDNA for … cfDNA kinetics after alloHSCT might be clinically useful. …

… In conclusion, these results suggest that GRFS is also a useful endpoint to assess transplant
… All patients were evaluable for hematopoietic recovery and chimerism status. Patients …

… in predicting relapse when pre-transplant MRD was known but not necessarily so when
disease status at transplant was … status is a useful predictor of relapse after allogeneic stem …

… by chimerism status. The median time to chimerism assessment was 84 days post-transplant
(… of ATG AUC, these clinical factors may be useful surrogate predictors of T-cell chimerism. …

… first allogenic hematopoietic stem-cell transplantation (allo-… after one, three and six months
to assess the disease status. In … highlighted the excellent negative predictive value of CC, …

… disease recurrence—in fact, we saw a reduction, even after … such factors as age, disease
status, and comorbidity score in our … molecular and genomic markers predictive of outcomes in …